FdaApplication
ANDA 202104
Identifiers
- fda_app_no: ANDA202104
Properties
| Property | Value |
|---|---|
| applicant_name | UPSHER SMITH LABORATORIES LLC |
| application_type | ANDA |
| approval_date | 2013-06-03 |
Products (7)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MORPHINE SULFATE | MORPHINE SULFATE | 50MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MORPHINE SULFATE | MORPHINE SULFATE | 20MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MORPHINE SULFATE | MORPHINE SULFATE | 100MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MORPHINE SULFATE | MORPHINE SULFATE | 80MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MORPHINE SULFATE | MORPHINE SULFATE | 60MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MORPHINE SULFATE | MORPHINE SULFATE | 30MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MORPHINE SULFATE | MORPHINE SULFATE | 10MG | CAPSULE, EXTENDED RELEASE;ORAL |
7 products